*Some Market data delayed by 15 mins.

Amgen Inc

Symbol: AMGN (NASDAQ)
299.46 ▲ (6.12%) 17.258

Company Description:
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Key Stats
  • Today's Open: $284.45
  • Today's High: $299.258
  • Today's Low: $280.46
  • Today's Volume: 1.72M
  • Yesterday Close: $282.2
  • Yesterday High: $284.815
  • Yesterday Low: $274.02
  • Yesterday Volume: 3.51M
  • Last Min Volume: 51.31K
  • Last Min High: $299.251
  • Last Min Low: $298.421
  • Last Min VWAP: $298.65139
Company Profile
  • Name: Amgen Inc
  • Website: https://www.amgen.com
  • Listed Date: 1983-06-17
  • Location: THOUSAND OAKS, CA
  • Market Status: Active
  • CIK Number: 0000318154
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $151.93B
  • Round Lot: 100
  • Outstanding Shares: 538.36M
  • Asset Type: CS
RECENT FILINGS FOR AMGN
Filing Date Filing Type Format
2025-09-08 SCHEDULE 13G/A View
2025-08-22 4 View
2025-08-20 144 View
2025-08-12 4 View
2025-08-12 4 View
2025-08-12 4 View
2025-08-06 10-Q View
2025-08-05 8-K View
2025-06-12 11-K View
2025-06-12 11-K View
2025-06-06 4 View
2025-06-05 144 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
2025-05-28 4 View
Latest News on AMGN

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.